Emcure Pharmaceuticals: Statement Of Deviation(S) Or Variation(S) Of Funds Under Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Quarter Ended September 30 2024

Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith statement of deviation(s) or variation(s) in utilization of proceeds raised through Initial Public Offer (IPO) for the quarter ended September 30 2024.